Literature DB >> 11155586

Antihistamines.

M W Greaves1.   

Abstract

In the 1990s, major improvements occurred in the therapeutic index of H1 antihistamines. The third-generation compounds promise to be more effective and nontoxic. The future major advances are likely to result from development and exploitation of non-H1 receptor-mediated antiallergic actions of these drugs.

Mesh:

Substances:

Year:  2001        PMID: 11155586     DOI: 10.1016/s0733-8635(05)70229-1

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  3 in total

1.  Use of cyproheptadine hydrochloride (HCl) to reduce neuromuscular hypertonicity in stroke survivors: A Randomized Trial: Reducing Hypertonicity in Stroke.

Authors:  Derek Kamper; Alexander Barry; Naveen Bansal; Mary Ellen Stoykov; Kristen Triandafilou; Lynn Vidakovic; NaJin Seo; Elliot Roth
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-08-30       Impact factor: 2.677

2.  Separate peripheral pathways for pruritus in man.

Authors:  Barbara Namer; Richard Carr; Lisa M Johanek; Martin Schmelz; Hermann O Handwerker; Matthias Ringkamp
Journal:  J Neurophysiol       Date:  2008-06-18       Impact factor: 2.714

Review 3.  Oral H1 antihistamines as monotherapy for eczema.

Authors:  Christian J Apfelbacher; Esther J van Zuuren; Zbys Fedorowicz; Aldrin Jupiter; Uwe Matterne; Elke Weisshaar
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.